Dr. Angevine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Hospital Plz
Stamford, CT 06902
Summary
- Dr. Anne Angevine is an hematologist and oncologist. She received her medical degree from Columbia University College of Physicians & Surgeons. She specializes in breast cancer and hematologic oncology and is experienced in treating leukemias, lymphomas, myeloma, myelodysplasia and myeloproliferative disorders, breast cancer as well as benign hematologic conditions.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2003 - 2007
- Brigham and Women's HospitalResidency, Internal Medicine, 2000 - 2003
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2000
- University of North Carolina at Chapel HillBA, Psychology, 1992 - 1996
- University of North Carolina at Chapel HillBA, Psychology, 1992 - 1996
- UNC-Chapel HillBA, Psychology, 1992 - 1996
Certifications & Licensure
- NY State Medical License 2002 - 2026
- CT State Medical License 2007 - 2025
- MO State Medical License 2004 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- BRAVA Award YWCA Greenwich, 2016
- Melville G. Magida Award Fairfield County Medical Association, 2011
Clinical Trials
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients Start of enrollment: 2010 Jan 01
- Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 02
Publications & Presentations
PubMed
- 5 citationsTherapy-induced thoracic malignancies.Lydia B. Zablotska, Anne H Angevine, Alfred I. Neugut
Clinics in Chest Medicine. 2004-03-01
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: